- Home
- XAIR vs BRNS Comparison
XAIR vs BRNS Comparison
Compare XAIR & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XAIR
- BRNS
- Stock Information
- Founded
- XAIR 2011
- BRNS 2016
- Country
- XAIR United States
- BRNS United Kingdom
- Employees
- XAIR N/A
- BRNS N/A
- Industry
- XAIR Medical/Dental Instruments
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- XAIR Health Care
- BRNS Health Care
- Exchange
- XAIR Nasdaq
- BRNS Nasdaq
- Market Cap
- XAIR 33.6M
- BRNS 36.7M
- IPO Year
- XAIR N/A
- BRNS 2021
- Fundamental
- Price
- XAIR $0.46
- BRNS $1.04
- Analyst Decision
- XAIR Strong Buy
- BRNS Strong Buy
- Analyst Count
- XAIR 4
- BRNS 2
- Target Price
- XAIR $3.67
- BRNS $4.00
- AVG Volume (30 Days)
- XAIR 731.9K
- BRNS 59.3K
- Earning Date
- XAIR 02-10-2025
- BRNS 11-06-2024
- Dividend Yield
- XAIR N/A
- BRNS N/A
- EPS Growth
- XAIR N/A
- BRNS N/A
- EPS
- XAIR N/A
- BRNS N/A
- Revenue
- XAIR $2,342,000.00
- BRNS $14,969,000.00
- Revenue This Year
- XAIR $230.80
- BRNS $1,805.74
- Revenue Next Year
- XAIR $265.55
- BRNS N/A
- P/E Ratio
- XAIR N/A
- BRNS N/A
- Revenue Growth
- XAIR 685.91
- BRNS 106.21
- 52 Week Low
- XAIR $0.30
- BRNS $0.80
- 52 Week High
- XAIR $2.36
- BRNS $4.16
- Technical
- Relative Strength Index (RSI)
- XAIR 47.58
- BRNS 50.96
- Support Level
- XAIR $0.44
- BRNS $0.80
- Resistance Level
- XAIR $0.50
- BRNS $1.05
- Average True Range (ATR)
- XAIR 0.04
- BRNS 0.13
- MACD
- XAIR -0.01
- BRNS 0.02
- Stochastic Oscillator
- XAIR 25.36
- BRNS 54.44
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.